Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy.
J Nucl Med
; 55(7): 1047-53, 2014 Jul.
Article
in En
| MEDLINE
| ID: mdl-24842891
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Radiation Dosage
/
Lymphoma, Non-Hodgkin
/
Radioimmunotherapy
/
Precision Medicine
/
Antibodies, Monoclonal
Type of study:
Guideline
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Nucl Med
Year:
2014
Document type:
Article